To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients
This study has been completed.
Information provided by (Responsible Party):
First received: December 4, 2012
Last updated: December 21, 2012
Last verified: February 2012
This protocol is intended to formally collect data on the treatment of aHUS with eculizumab in Japanese patients.
ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)
|Study Design:||Time Perspective: Retrospective|
|Official Title:||A Research Study to Describe the Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS). An Assessment of Two Case Studies|
Resource links provided by NLM:
Genetic and Rare Diseases Information Center resources: Hemolytic Uremic Syndrome Atypical Hemolytic Uremic SyndromeU.S. FDA Resources
Further study details as provided by Alexion Pharmaceuticals:
Contacts and Locations